Denmark has revised its economic growth forecast for 2025, reducing expectations by more than 50 percent. The downward adjustment reflects concerns over the country’s economic outlook amid weaker prospects for key industries, particularly in the pharmaceutical sector.
The revision comes in the wake of lowered forecasts for Novo Nordisk, Denmark’s leading pharmaceutical company, which has faced challenges impacting its growth potential. Analysts and government officials cited these developments as significant factors contributing to the revised economic outlook for the coming year.
While Denmark’s economy has generally been resilient, the new forecast indicates increased uncertainties and potential headwinds ahead. Economic policymakers are closely monitoring the situation and may consider adjustments to their strategies to support growth amid these revised projections.
The specific details of the new forecast have not been publicly released, but the downward revision underscores concerns about the impact of global and regional economic conditions on Denmark’s key industries and overall growth trajectory.